Titan Optical has added the whole suite of Oculus ophthalmic imaging and diagnostic devices to its portfolio.
Titan Optical founder and director Cam Gordon said the company was approached by Oculus, which was in the market for a new distribution partner in New Zealand. “Both parties determined it would be a good fit and I’m thrilled to have Oculus on board. We do really well with our laser and ultrasound products and I attribute a lot of that to them being phenomenal quality products with great reputations. I think Oculus brings that to our portfolio for imaging and diagnostics.”
Oculus’s latest innovation, the Pentacam Cornea OCT, is the next step in corneal analysis for practitioners, said Gordon. “It provides all the same excellent quality information people are used to getting from their Pentacam, but now adding a level of corneal OCT that really stands out. Users just need to look at the quality of OCTs on the Oculus website to understand what I’m talking about. For existing users, they can keep their existing database and just continue to build on it.”
The Pentacam Cornea OCT is now available through Titan Optical but there’s a slight delay getting it into the country due to high demand, said Gordon. “I’d encourage anyone curious about the Oculus portfolio to reach out and ask questions. Having just returned from product training, I’ve learnt a lot about how deep the portfolio is. While the K5M and Pentacam are what Oculus is really known for, it has many other really impressive products: fast-screening visual-field units, full-size perimeters, optical biometers, slit-lamp cameras and corneal analysers. There really is a lot on offer,” he said.
It's worth keeping a close eye on the Oculus Corvis ST, a biomechanical corneal analyser, Gordon said. “The information it can collect is huge, as are the current and future applications of that information!”
